SynthesisFrontiers in oncology2026

Efficacy and safety of immune checkpoint inhibitors plus chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis.

Jia-Le Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.